Literature DB >> 2783528

Acute gastrointestinal bleeding in anticoagulated patients: a prospective evaluation.

N Tabibian1.   

Abstract

Acute gastrointestinal hemorrhage is one of the most feared complications of anticoagulation therapy. We prospectively evaluated 18 episodes of acute gastrointestinal bleeding in 17 patients anticoagulated with coumadin or heparin. Endoscopic examination revealed significant lesions irrespective of age, duration of anticoagulation, level of anticoagulation or symptoms. The high frequency of objective findings (e.g., 44% ulcers) suggests that diagnostic endoscopy should be performed in patients with acute gastrointestinal bleeding associated with anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783528

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

1.  Prevalence of significant neoplasia in FOBT-positive patients on warfarin compared with those not on warfarin.

Authors:  Lulu Iles-Shih; Judy F Collins; Jennifer L Holub; David A Lieberman
Journal:  Am J Gastroenterol       Date:  2010-08-03       Impact factor: 10.864

Review 2.  Risk-benefit assessment of anticoagulant therapy.

Authors:  R Harrington; J Ansell
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

3.  Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment.

Authors:  C P Choudari; C Rajgopal; K R Palmer
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

4.  Anticoagulation in patients with atrial fibrillation. Don't deny treatment to elderly people.

Authors:  T Solanki
Journal:  BMJ       Date:  1993-12-04

5.  Acute major gastrointestinal bleeding caused by hookworm infection in a patient on warfarin therapy: A case report.

Authors:  Yu Meng; FangGen Lu; Lin Shi; MeiChu Cheng; Jie Zhang
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.